Tag: China

First China’s P4P Program for Cancer by Pfizer

Pfizer Inc. launched a pay-for-performance insurance program for its breast cancer drug Ibrance palbociclib in China. The program is the nation's first pay-for-performance insurance for oncology and c...

Boehringer Expands Capacity Expansion at Chinese Site

Upgrade at the Oasis facility includes GMP operations of 2x 2.000L single-use bioreactor manufacturing lines. Boehringer Ingelheim has initiated a capacity expansion at its commercial manufacturing...

AstraZeneca and Ironwood’s IBS-C Drug Approved in China

Ironwood Pharmaceuticals’ irritable bowel syndrome treatment Linzess has gained approval in China, opening up a market of up to 14m adults with the condition. The good news coincides with big chang...

Chinese Company will Use US Tests in Cancer Therapy

The Xiamen Encheng Group Co., Ltd., a pharmaceutical services and precision medicine-focused company located in Xiamen City, Fujian Province, China, announced today that it has entered into a strategi...

Pall Established Biotech Integrated Solutions CoE in Shanghai

Strategically located in the heart of Shanghai’s renowned life science cluster, the CoE is a new state-of-the-art facility for bioprocess engineering consultancy, technology demonstration, testing and...

WuXi AppTec Expands US Facility

WuXi AppTec, headquartered in Shanghai, China, plans to expand its facilities in San Diego. WuXi AppTec describes itself as “a leading global pharmaceutical and medical device open-access capabilit...

Catalent in Shanghai has reached the commissioning Stage

Catalent Pharma Solutions has announced that work to expand its primary packaging capabilities at its clinical facility in Shanghai, China, has reached the commissioning stage and is scheduled to be c...

Lonza to set up a new biologics facility using GE Healthcare’s platform

test tube
Lonza (Switzerland) announced an agreement with GE Healthcare (USA) under which GE Healthcare will deliver a biologics facility to Lonza in Guangzhou (China).

Chinese company to invest $150 million in biologics manufacturing

Changzhou Qianhong Bio-pharma started construction of the phase two of pharmaceuticals production facility at Changzhou National Hi-Tech District (China).

Thermo Fisher Scientific starts the Bioprocess Design Center in China

Thermo Fisher Scientific, the world leader in serving science, opened its first Bioprocess Design Center in Shanghai (China).

Sanofi to establish a research institute in China

French pharmaceutical company Sanofi is planning to set up its first research institute in the eastern city of Suzhou (China) to further expand its presence in the world's most populous country.

CASI Pharmaceuticals to build new manufacturing site in China

CASI Pharmaceuticals nnounced that it has entered into framework agreements to build a state-of-the-art manufacturing site in the Wuxi Huishan Economic Development Zone.

Sanofi conducted the China Health Road Symposium in Shanghai

Sanofi held the China Health Road Symposium in Shanghai (China) during the first edition of China International Import Expo (CIIE) exhibition that was conducted for five days

Catalent to set up its second clinical supply facility in China

clinical trial
Catalent Pharma Solutions announced its plans to invest $2.5 million in a new, second clinical supply facility in Shanghai, China, due to open in early 2019.

Merck KGaA to establish an innovation hub in Guangzhou

Merck KGaA signed an agreement with the Guangzhou Development District on innovation development in Southern China. Merck KGaA to establish an innovation hub in Guangzhou.

New multi-targeting oligosaccharide drug could give hope to Alzheimer patients

alzheimer's disease
According to lead researcher Geng Meiyu, GV-971, a multi-targeting oligosaccharide drug developed by a Chinese research group, could give Alzheimer patients hope.